BridgeBio Pharma (BBIO) Q3 2026 Earnings

30JulConfirmed
Q4 2025
Q1 2026
Q2 2026
Next
-1
-0.86
-0.73
-0.59

Details

Expected EPS
-0.59031
Actual EPS
N/A
Surprise EPS
0.59
Surprise Percent
+100%

Description

BridgeBio Pharma (BBIO) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts